Literature DB >> 6150246

Review of mortality results in randomised trials in early breast cancer.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6150246

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Breast Cancer: A Revolutionary Concept.

Authors: 
Journal:  Breast Cancer       Date:  1995-04-30       Impact factor: 4.239

Review 2.  Breast cancer. Advances in management.

Authors:  G N Brodie; A Elefanty
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

3.  Adjuvant chemotherapy in postmenopausal women: results of sequential noncross-resistant regimens.

Authors:  C Brambilla; A Rossi; P Valagussa; G Bonadonna
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

4.  Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.

Authors:  A J Wilson; M Baum; D M Brinkley; J A Dossett; K McPherson; J S Patterson; R D Rubens; F G Smiddy; B A Stoll; D Richards
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

5.  What does homoeopathy do--and how?

Authors:  R Buckman; G Lewith
Journal:  BMJ       Date:  1994-07-09

6.  The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect.

Authors:  L E Rutqvist; B Cedermark; U Glas; H Johansson; B Nordenskjöld; L Skoog; A Somell; T Theve; S Friberg; J Askergren
Journal:  Breast Cancer Res Treat       Date:  1987-12       Impact factor: 4.872

Review 7.  Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.

Authors:  V Craig Jordan; Angela M H Brodie
Journal:  Steroids       Date:  2006-12-13       Impact factor: 2.668

Review 8.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Tissue polypeptide antigen in tumor cytosol: a new prognostic indicator in primary breast cancer.

Authors:  M Gion; R Mione; C Gatti; R Dittadi; A Leon; C Castiglioni; O Nascimben; G Bruscagnin
Journal:  Breast Cancer Res Treat       Date:  1990-11       Impact factor: 4.872

10.  History of evidence synthesis to assess treatment effects: Personal reflections on something that is very much alive.

Authors:  Mike Clarke
Journal:  J R Soc Med       Date:  2016-04       Impact factor: 5.344
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.